About: NanOlogy
Profile:
Posts by NanOlogy:
- NanOlogy to Unveil Positive Preclinical Data for Inhaled NanoPac® in Treatment of Lung Cancer at 2018 ASCO Annual Meeting (May 29, 2018 - NanOlogy Press Release)
- Boston Business Journal: NanOlogy Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac for Treatment of Prostate Cancer (May 3, 2018 - NanOlogy in the News)
- NanOlogy Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer (April 30, 2018 - NanOlogy Press Release)
- NanOlogy to Present Abstract on Preclinical Study of Nebulized NanoPac for Lung Cancer at 2018 ASCO Annual Meeting (April 25, 2018 - NanOlogy Press Release)
- BioCentury: Tiny Taxanes – How Nanology’s Particle Production Technology Created Submicron Chemotherapy (April 9, 2018 - NanOlogy in the News)
- Drug Delivery: NanOlogy looks to transform chemotherapy with localized delivery platform (March 5, 2018 - NanOlogy in the News)
- Drug Development: NanOlogy Submicron Particle Platform Transforms Systemic Chemotherapy Into Local Delivery (February 28, 2018 - NanOlogy in the News)
- DermWire: NanOlogy Enrolls First Patient in Clinical Trial for Cutaneous Metastases (February 14, 2018 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial for Cutaneous Metastases and DFB Soria Provides an Update on AK Trial (February 14, 2018 - NanOlogy Press Release, Soria)
- Houston Business Journal: NanOlogy to Update Clinical Program at BIO CEO Conference (February 5, 2018 - NanOlogy in the News)
- NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference (February 5, 2018 - NanOlogy Press Release, Soria)
- PharmaVOICE: Next-Generation Nanomedicines (January 3, 2018 - NanOlogy in the News)
- NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco (January 3, 2018 - NanOlogy Press Release, Soria)
- Drug Delivery Business: NanOlogy takes nanoparticle tech into Phase II trials (December 19, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase 2 Clinical Trial of NanoPac® Adding to Trials in Prostate and Ovarian Cancers (December 18, 2017 - NanOlogy Press Release, Soria)
- Clinical Leader: Trial Aims To Kill Cancer Without Chemotherapy Side Effects (November 20, 2017 - NanOlogy in the News)
- DDNEWS: New Cancer Answer (November 13, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Mucinous Cysts of the Pancreas (November 7, 2017 - NanOlogy Press Release, Soria)
